• Explore /
  • Poster
  • / SKB264 (TROP2-ADC) for the treatment of patients with advanced NSCLC: Efficacy and safety data from a phase 2 study.

SKB264 (TROP2-ADC) for the treatment of patients with advanced NSCLC: Efficacy and safety data from a phase 2 study.

Abstract Poster

Authors

null

Wenfeng Fang

Department of Medical Oncology, Sun Yat-sen University Cancer Center & State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China

Wenfeng Fang , Ying Cheng , Zhendong Chen , Wei Wang , Yongmei Yin , Yongsheng Li , Huiting Xu , Xingya Li , Zev A. Wainberg , Guohua Yu , Yanjun Mi , Jordi Rodon Ahnert , Xiang Wang , Xian Wang , Yina Diao , Yalan Yang , Lian Lu , Junyou Ge , Jin Li , Li Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04152499

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9114)

DOI

10.1200/JCO.2023.41.16_suppl.9114

Abstract #

9114

Poster Bd #

102

Abstract Disclosures

Similar Posters

First Author: Tony S. K. Mok

First Author: Yongheng Liu

First Author: Jonathan N. Priantti

First Author: Charu Aggarwal